• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

GAiT.Global

The Global Alliance for iPSC Therapies

  • About GAiT
    • About GAiT
    • Sponsors
      • NYSCF
      • KHiB
      • CCRM
      • INSERM
      • HKU
      • CGT
    • Support Us
  • News & Events
  • Publications
  • Workshops
  • Quality Assessment Rounds
  • Database
  • Portal Login
You are here: Home / Board Members / CGT

CGT

cgt

A centre of excellence

The Cell and Gene Therapy Catapult is a centre of excellence in innovation, with the core purpose of building a world-leading cell and gene therapy sector in the UK as a key part of a global industry. Supported by Innovate UK, our mission is to drive the growth of the industry by helping cell and gene therapy organisations across the world translate early stage research into commercially viable and investable therapies. We are based on the 12th floor of Guy’s Hospital in central London, with over 120 cell and gene therapy experts, state-of-the art development and viral vector laboratories. We are also building a £55m large-scale GMP manufacturing centre to help bring cell and gene therapies to market in the UK and internationally.

Our vision

The Cell and Gene Therapy Catapult vision is for the UK to be a global leader in the development, delivery and commercialisation of cell and gene therapy. Where businesses can start, grow and confidently develop cell and gene therapies, delivering them to patients rapidly, efficiently and effectively.

Our mission

Our mission is to grow the industry in the UK to substantial and sustainable levels by:

  • taking products into clinical trial, de-risking them for further investment;
  • providing clinical expertise and access to NHS clinical partners;
  • providing technical expertise and infrastructure to ensure products can be made to GMP and delivered cost effectively;
  • providing regulatory expertise to ensure that products can get to the clinic safely, in the shortest amount of time;
  • providing opportunities for collaboration, both nationally and globally; and
  • providing access to business expertise, grants and investment finance so that commercially viable products are progressed and investable propositions are generated.

Primary Sidebar

Search Users

GAiT News

IPSCtherapies avatarGAiT@IPSCtherapies·
17 Jan 1350802772917149696

iPSC Quality Assessment Round Participants were sent an update on manuscript development last Friday 15th JAN 2021.

Reply on Twitter 1350802772917149696Retweet on Twitter 1350802772917149696Like on Twitter 1350802772917149696Twitter 1350802772917149696
IPSCtherapies avatarGAiT@IPSCtherapies·
5 Jan 1346318965086310402

Congratulations to @CCRM_ca on their 10th birthday. A unique organization facilitating efficient ATMP development and a great resource to regenerative medicine research in Canada.

Reply on Twitter 1346318965086310402Retweet on Twitter 13463189650863104021Like on Twitter 1346318965086310402Twitter 1346318965086310402
IPSCtherapies avatarGAiT@IPSCtherapies·
18 Dec 1339866026293547009

GAiT wishes our members and collaborators a restful and restorative holiday over the coming weeks. Our thoughts are with those lost or sick due to COVID-19, and also the Frontline Healthcare Professionals, who are bravely managing this unprecedented medical emergency.

Reply on Twitter 1339866026293547009Retweet on Twitter 1339866026293547009Like on Twitter 1339866026293547009Twitter 1339866026293547009
Load More...

Invite Users to Site

Invite another user onto the GAiT Website

Social media

Follow us on social media

GAiT LinkedIn GAit Sound Cloud GAiT Twitter

 

 

Newsletter





© 2021 GAiT. All Rights reserved. Web Design by Conceptstore
  • Home
  • Portal Login